Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19

Showing 19 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: Combination cancer chemotherapy, immunotherapy and gene therapy
Zheng Wang, Shuo Pang, Xiaoli Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132579-132579
Closed Access | Times Cited: 35
Hyaluronan-decorated copper-doxorubicin-anlotinib nanoconjugate for targeted synergistic chemo/chemodynamic/antiangiogenic tritherapy against hepatocellular carcinoma
Gang Tan, Guanghui Hou, Junmin Qian, et al.
Journal of Colloid and Interface Science (2024) Vol. 662, pp. 857-869
Closed Access | Times Cited: 9
ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription
Dandan Wu, Zongchao Zuo, Xinning Sun, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116206-116206
Closed Access | Times Cited: 8
Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy
Lingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Biomaterials (2024) Vol. 313, pp. 122766-122766
Closed Access | Times Cited: 8
Nanoparticles as Drug Delivery Carrier-synthesis, Functionalization and Application
Drishya Sajeevan, Ramakrishna Prasad Are, Prabhudutta Hota, et al.
Current Pharmaceutical Design (2024) Vol. 31, Iss. 4, pp. 244-260
Closed Access | Times Cited: 4
Metal-organic framework nanoparticles activate cGAS-STING pathway to improve radiotherapy sensitivity
Xinyao Hu, Hua Zhu, Yang Shen, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
A cascade nanosystem with “Triple-Linkage” effect for enhanced photothermal and activatable metal ion therapy for hepatocellular carcinoma
Shuo Yu, Huan Shen, Xi Chen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Anti-liver cancer effects and mechanisms and its application in nano DDS of polysaccharides: A review
Yan Zheng, Hanqing Chen
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135181-135181
Closed Access | Times Cited: 3
Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironment
Daniel Cecchi, Nolan Jackson, Wayne Beckham, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 175-175
Open Access | Times Cited: 2
Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023
Yuhui Hou, Yue Li, Youao Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Biotinylated polyaminoacid-based nanoparticles for the targeted delivery of lenvatinib towards hepatocarcinoma
Paola Varvarà, Salvatore Emanuele Drago, E. Esposito, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124537-124537
Closed Access | Times Cited: 1
Hispolon-loaded lipid nanocapsules for the management of hepatocellular carcinoma: comparative study with solid lipid nanoparticles and suspension
Nabil K. Alruwaili, Waleed Hassan Almalki, Salem Salman Almujri, et al.
Nanomedicine (2024), pp. 1-22
Closed Access | Times Cited: 1
Nanotechnology-based combinational strategies toward the regulation of myofibroblasts and diseased microenvironment in liver fibrosis and hepatic carcinoma
Fenfen Li, Ying Zhao, Guangjun Nie
Nano Research (2023) Vol. 16, Iss. 12, pp. 13042-13055
Closed Access | Times Cited: 2
Adsorption of Dacarbazine as Anticancer Drug on Si60, C60, B30N30, Sc-Si60, Sc-C60, Sc-B30N30 Nanocages
Junjuan Zhang, Xiangtao Yu, Jing Wang, et al.
Silicon (2024) Vol. 16, Iss. 15, pp. 5563-5570
Closed Access
Nanoparticle-based delivery system for normalization of liver sinusoidal endothelial cells in hepatocellular carcinoma
Shufen Chen, Lin Jin, Zhiping Zeng, et al.
Materials & Design (2024) Vol. 245, pp. 113242-113242
Open Access
Nanotechnology‐Enabled Targeted Protein Degradation for Cancer Therapeutics
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
Nanoparticles and the treatment of hepatocellular carcinoma
Ziyu Zhang, Weihua Cao, Xinxin Li, et al.
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access
Page 1

Scroll to top